310 related articles for article (PubMed ID: 30584278)
21. Dinuclear copper complexes of organic claw: potent inhibition of protein tyrosine phosphatases.
Ma L; Lu L; Zhu M; Wang Q; Gao F; Yuan C; Wu Y; Xing S; Fu X; Mei Y; Gao X
J Inorg Biochem; 2011 Sep; 105(9):1138-47. PubMed ID: 21708098
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and biological evaluation of novel N-aryl-ω-(benzoazol-2-yl)-sulfanylalkanamides as dual inhibitors of α-glucosidase and protein tyrosine phosphatase 1B.
Wang MY; Cheng XC; Chen XB; Li Y; Zang LL; Duan YQ; Chen MZ; Yu P; Sun H; Wang RL
Chem Biol Drug Des; 2018 Sep; 92(3):1647-1656. PubMed ID: 29745030
[TBL] [Abstract][Full Text] [Related]
23. Potent inhibition of protein tyrosine phosphatases by copper complexes with multi-benzimidazole derivatives.
Li Y; Lu L; Zhu M; Wang Q; Yuan C; Xing S; Fu X; Mei Y
Biometals; 2011 Dec; 24(6):993-1004. PubMed ID: 21618062
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and biological evaluation of 2,4,6-trihydroxychalcone derivatives as novel protein tyrosine phosphatase 1B inhibitors.
Sun LP; Gao LX; Ma WP; Nan FJ; Li J; Piao HR
Chem Biol Drug Des; 2012 Oct; 80(4):584-90. PubMed ID: 22805439
[TBL] [Abstract][Full Text] [Related]
25. Design and Biological Evaluation of Novel Imidazolyl Flavonoids as Potent and Selective Protein Tyrosine Phosphatase Inhibitors.
Han RY; Ge Y; Zhang L; Wang QM
Med Chem; 2020; 16(4):563-574. PubMed ID: 31208312
[TBL] [Abstract][Full Text] [Related]
26. [Design, synthesis and evaluation of malonic acid-based PTP1B inhibitors].
Du X; Zhang SE; Liu JZ; Nie FL; Ye F; Tian JY; Xiao ZY
Yao Xue Xue Bao; 2012 Mar; 47(3):367-73. PubMed ID: 22645761
[TBL] [Abstract][Full Text] [Related]
27. Docking analysis targeted to the whole enzyme: an application to the prediction of inhibition of PTP1B by thiomorpholine and thiazolyl derivatives.
Ganou CA; Eleftheriou PT; Theodosis-Nobelos P; Fesatidou M; Geronikaki AA; Lialiaris T; Rekka EA
SAR QSAR Environ Res; 2018 Feb; 29(2):133-149. PubMed ID: 29347844
[TBL] [Abstract][Full Text] [Related]
28. Prediction of enzyme inhibition and mode of inhibitory action based on calculation of distances between hydrogen bond donor/acceptor groups of the molecule and docking analysis: An application on the discovery of novel effective PTP1B inhibitors.
Eleftheriou P; Petrou A; Geronikaki A; Liaras K; Dirnali S; Anna M
SAR QSAR Environ Res; 2015; 26(7-9):557-76. PubMed ID: 26294069
[TBL] [Abstract][Full Text] [Related]
29. Identification of protein tyrosine phosphatase 1B (PTP1B) inhibitors through De Novo Evoluton, synthesis, biological evaluation and molecular dynamics simulation.
Wu J; Ma Y; Zhou H; Zhou L; Du S; Sun Y; Li W; Dong W; Wang R
Biochem Biophys Res Commun; 2020 May; 526(1):273-280. PubMed ID: 32209254
[TBL] [Abstract][Full Text] [Related]
30. Discovery of novel, high potent, ABC type PTP1B inhibitors with TCPTP selectivity and cellular activity.
Liu P; Du Y; Song L; Shen J; Li Q
Eur J Med Chem; 2016 Aug; 118():27-33. PubMed ID: 27123900
[TBL] [Abstract][Full Text] [Related]
31. Allosteric Inhibitors of SHP2 with Therapeutic Potential for Cancer Treatment.
Xie J; Si X; Gu S; Wang M; Shen J; Li H; Shen J; Li D; Fang Y; Liu C; Zhu J
J Med Chem; 2017 Dec; 60(24):10205-10219. PubMed ID: 29155585
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and biological evaluation of open-chain analogs of cyclic peptides as inhibitors of cellular Shp2 activity.
Zhen XL; Yin WH; Tian X; Ma ZJ; Fan SM; Han JR; Liu S
Bioorg Med Chem; 2015 May; 23(10):2562-7. PubMed ID: 25865131
[TBL] [Abstract][Full Text] [Related]
33. Rational design of allosteric-inhibition sites in classical protein tyrosine phosphatases.
Chio CM; Yu X; Bishop AC
Bioorg Med Chem; 2015 Jun; 23(12):2828-38. PubMed ID: 25828055
[TBL] [Abstract][Full Text] [Related]
34. Novel PROTACs for degradation of SHP2 protein.
Zheng M; Liu Y; Wu C; Yang K; Wang Q; Zhou Y; Chen L; Li H
Bioorg Chem; 2021 May; 110():104788. PubMed ID: 33706076
[TBL] [Abstract][Full Text] [Related]
35. From Pyrazolones to Azaindoles: Evolution of Active-Site SHP2 Inhibitors Based on Scaffold Hopping and Bioisosteric Replacement.
Mostinski Y; Heynen GJJE; López-Alberca MP; Paul J; Miksche S; Radetzki S; Schaller D; Shanina E; Seyffarth C; Kolomeets Y; Ziebart N; de Schryver J; Oestreich S; Neuenschwander M; Roske Y; Heinemann U; Rademacher C; Volkamer A; von Kries JP; Birchmeier W; Nazaré M
J Med Chem; 2020 Dec; 63(23):14780-14804. PubMed ID: 33210922
[TBL] [Abstract][Full Text] [Related]
36. Inhibitors of Src homology-2 domain containing protein tyrosine phosphatase-2 (Shp2) based on oxindole scaffolds.
Lawrence HR; Pireddu R; Chen L; Luo Y; Sung SS; Szymanski AM; Yip ML; Guida WC; Sebti SM; Wu J; Lawrence NJ
J Med Chem; 2008 Aug; 51(16):4948-56. PubMed ID: 18680359
[TBL] [Abstract][Full Text] [Related]
37. Molecular dynamics approach to probe the allosteric inhibition of PTP1B by chlorogenic and cichoric acid.
Baskaran SK; Goswami N; Selvaraj S; Muthusamy VS; Lakshmi BS
J Chem Inf Model; 2012 Aug; 52(8):2004-12. PubMed ID: 22747429
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of SHP2 by new compounds induces differential effects on RAS/RAF/ERK and PI3K/AKT pathways in different cancer cell types.
Vazhappilly CG; Saleh E; Ramadan W; Menon V; Al-Azawi AM; Tarazi H; Abdu-Allah H; El-Shorbagi AN; El-Awady R
Invest New Drugs; 2019 Apr; 37(2):252-261. PubMed ID: 29947013
[TBL] [Abstract][Full Text] [Related]
39. Protein Tyrosine Phosphatase (PTP1B): A promising Drug Target Against Life-threatening Ailments.
Kumar A; Rana D; Rana R; Bhatia R
Curr Mol Pharmacol; 2020; 13(1):17-30. PubMed ID: 31339082
[TBL] [Abstract][Full Text] [Related]
40. The Discovery of Potent SHP2 Inhibitors with Anti-Proliferative Activity in Breast Cancer Cell Lines.
Ghemrawi R; Khair M; Hasan S; Aldulaymi R; AlNeyadi SS; Atatreh N; Ghattas MA
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457286
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
